Metabolic Effects of 7 Antipsychotics on Patients With Schizophrenia
- 24 March 2020
- journal article
- research article
- Published by Physicians Postgraduate Press, Inc
- Vol. 81 (3)
- https://doi.org/10.4088/JCP.19m12785
Abstract
How soon is too soon to look for metabolic syndrome in your patients with schizophrenia? This randomized open-label trial investigates 7 risk factors of 5 atypical and 2 typical antipsychotics to make recommendations for monitoring metabolic measurements.Keywords
This publication has 35 references indexed in Scilit:
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsWorld Psychiatry, 2013
- The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophreniaInternational Clinical Psychopharmacology, 2013
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated PatientsSchizophrenia Bulletin, 2012
- Monitoring cardiometabolic risk in schizophreniaThe British Journal of Psychiatry, 2012
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-AnalysisSchizophrenia Bulletin, 2011
- Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophreniaSchizophrenia Research, 2010
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different DrugsBiological Psychiatry, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter studyInternational Clinical Psychopharmacology, 2009
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1Schizophrenia Research, 2008